早期立体定向放射外科治疗药物难治性三叉神经痛
该回顾性研究纳入2006至2014年间108例药物难治性特发性三叉神经痛患者,均接受伽玛刀放射外科治疗,靶点为三叉神经根进入区,中位最大剂量90 Gy、等剂量线20%。中位潜伏期4周后,86例(90%)获得完全或充分疼痛缓解;中位17个月时22例(26%)疼痛复发,59例(55%)出现新发面部麻木。疼痛病史≤5年是疼痛缓解的显著预测因素,且与更短缓解潜伏期相关。
要点
- 伽玛刀放射外科治疗药物难治性特发性三叉神经痛,86/108例(90%)获得完全或充分疼痛缓解。
- 疼痛病史≤5年是疼痛缓解的显著预测因素(单因素P=0.049,多因素P=0.045)。
- 疼痛病史>5年患者缓解潜伏期长于≤5年患者(P=0.027)。
核心结论
- 伽玛刀放射外科在药物难治性特发性三叉神经痛患者中实现高比例疼痛缓解,疼痛病史≤5年是可预测疼痛缓解的可靠因素,且似乎与更短缓解潜伏期相关,因此推荐对此类患者早期行伽玛刀放射外科治疗。
研究设计与样本
- 回顾性综述,纳入2006至2014年间108例连续药物难治性特发性三叉神经痛患者,均接受伽玛刀放射外科治疗,靶点为神经根进入区,中位最大剂量90 Gy,等剂量线20%。
主要发现
- 中位潜伏期4周后,86/108例(90%)获得完全或充分疼痛缓解(巴罗神经学研究所评分I-IIIB)。
- 中位时间17个月时,22例(26%)出现疼痛复发。
- 59例(55%)报告新发面部麻木。
- 疼痛病史>5年患者较≤5年患者疼痛缓解潜伏期更长(P=0.027)。
- 单因素和多因素分析显示疼痛病史≤5年是疼痛缓解的显著预测因素(P=0.049和P=0.045)。
临床怎么用
- 作者认为,对药物难治性特发性三叉神经痛患者,疼痛病史≤5年可预测疼痛缓解且与更短缓解潜伏期相关,因此推荐早期行伽玛刀放射外科治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate effectiveness of early Gamma Knife radiosurgery (GKRS) in treatment of medically refractory trigeminal neuralgia (TN). METHODS: This retrospective review comprised 108 consecutive patients with medically refractory idiopathic TN between 2006 and 2014. All patients underwent GKRS targeting the root entry zone with a median maximum dose of 90 Gy and isodose line of 20%. Outcomes pertaining to pain and facial numbness were scored using Barrow Neurological Institute scales. RESULTS: Following a median latency period of 4 weeks, we observed complete or adequate pain relief (Barrow Neurological Institute scores of I-IIIB) in 86 of 108 patients (90%). At a median time of 17 months, 22 patients (26%) experienced pain recurrence. New-onset facial numbness was reported by 59 patients (55%). Treatment failure rates were highest among patients with a longer history of pain. Compared with patients with pain history of ≤5 years, patients with pain history of >5 years experienced longer latency before pain relief (P = 0.027). Univariate and multivariate analyses demonstrated that pain history of ≤5 years was a significant predictor of pain relief (P = 0.049 and P = 0.045, respectively). CONCLUSIONS: GKRS achieves a high rate of pain relief among patients with medically refractory idiopathic TN. Pain history of ≤5 years is a reliable predictor of pain relief and appears to be associated with shorter latency to pain relief after GKRS. Therefore, early GKRS for patients with medically refractory idiopathic TN is recommended.
引用
- Lee CC, Chen CJ, Chong ST, et al. Early Stereotactic Radiosurgery for Medically Refractory Trigeminal Neuralgia. World Neurosurg. 2018. PMID: 29371169. doi:10.1016/j.wneu.2018.01.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。